Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1396-2025Class I

CVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic...

Calyxo, Inc. / initiated 2025-02-19 / Open, Classified / root cause: design

Calyxo, Inc. began a recall of CVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic examination/treatment of urinary tract and kidney interior on . FDA classified it as Class I and gives the reason as "Aspiration system, for endoscopic examination/treatment of urinary tract and kidney interior, to have labeling update adding additional instructions, for patients with high viscosity fluid in the kidney, not to continue...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-1396-2025
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Calyxo, Inc.
Product
CVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic examination/treatment of urinary tract and kidney interior.
Product code
FED Endoscopic Access Overtube, Gastroenterology-Urology
Reason for recall
Aspiration system, for endoscopic examination/treatment of urinary tract and kidney interior, to have labeling update adding additional instructions, for patients with high viscosity fluid in the kidney, not to continue providing fluid inflow in the presence of unresolved slow or absent fluid outflow because this can create intrarenal pressure imbalance, and lead to excessive intrarenal pressure.
Root cause tag
design
FDA root cause
Device Design
Action
On 2/19/2025, correction notices were mailed to distributors and healthcare providers who were asked to do the following: 1) Notify all urologists utilizing the affected aspiration system in your institution that additional instructions are required. Please provide each of them with a copy of the additional instructions. 2) As another safety step, a firm representative will be contacting all users from your institution directly to offer training on these additional instructions. If you prefer to coordinate the training, please specifically state that preference in the acknowledgement. 3) Please acknowledge receipt of the notice, additional instructions, and updated training instructions MA00100.A by emailing [email protected], or calling 833-214-3354 and providing your name, title, institution and address.
Quantity in commerce
11,246
Distribution
US Nationwide distribution including in the states of AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, WV.
Product codes and lots
CVC127020-1 UDI-DI: 00860005357710, L00018 Rev C

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1396-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1396-2025Class IOngoingVoluntary: Firm initiated